Quotient Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+564
New +$209K 0.01% 378
2024
Q4
Sell
-621
Closed -$323K 328
2024
Q3
$323K Sell
621
-14
-2% -$7.48K 0.01% 238
2024
Q2
$344K Buy
635
+24
+4% +$12.7K 0.01% 225
2024
Q1
$317K Buy
611
+74
+14% +$36.8K 0.01% 223
2023
Q4
$253K Buy
+537
New +$248K 0.01% 244

Other funds holding ELV

Quotient Wealth Partners's ELV Position: Q2 2026 in Review

Quotient Wealth Partners opened a new position in Elevance Health (ELV) in Q2 2026: 564 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #378 among its holdings. This is a return to the name: Quotient Wealth Partners previously reported a position in ELV as recently as Q3 2024.

Quotient Wealth Partners first reported a position in ELV in Q4 2023 and has held it in 5 quarters since. The position peaked at $344K in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Quotient Wealth Partners held 564 shares of Elevance Health worth $218K as of Q2 2026.
  • Elevance Health was a new Quotient Wealth Partners position in Q2 2026.
  • Elevance Health made up 0.01% of Quotient Wealth Partners's portfolio in Q2 2026, its #378 holding.
  • Quotient Wealth Partners first reported a position in Elevance Health in Q4 2023 and has held it in 5 quarters since.
  • Quotient Wealth Partners's Elevance Health position peaked at $344K in Q2 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.